PMWC - Precision Medicine World Conference
Genetic Diversity in African Populations Can Advance Precision Medicine Globally
February 8th 2025Africa's unparalleled genetic diversity presents both a challenge and an opportunity to advance precision medicine, with a focus on leveraging pharmacogenetics to improve drug efficacy and reduce adverse reactions.
Unveiling the Dark Genome: Targeting Stress-Activated Base Editors to Halt Cancer Progression
February 7th 2025Catriona Jamieson, MD, PhD, discusses the role of stress-activated base editors like ADAR1p150 and APOBEC enzymes in cancer progression and highlights innovative approaches to halt these processes and improve therapeutic outcomes.
Gamma Delta T Cells Unlock New Advances in Cancer Immunotherapy
February 7th 2025γδ T cells are emerging as a transformative immunotherapy approach in oncology, offering unique mechanisms for targeting hematologic and solid tumors, with clinical trials demonstrating promising survival outcomes and durable immune responses.
Pharmacists Play a Vital Role in Addressing Patient Leakage in the Precision Medicine Care Continuum
February 6th 2025Edward Kim, MD, MBA, discusses critical points of patient leakage in precision medicine, emphasizing the role of multidisciplinary teams in streamlining care, managing medications, and improving patient outcomes.
Bridging Gaps in Precision Medicine: Overcoming Patient Leakage and Advancing Personalized Care
February 5th 2025Edward Kim, MD, MBA, highlights the challenges of patient disengagement, data fragmentation, and provider education in precision medicine, emphasizing the need for personalized approaches to enhance patient outcomes, particularly in oncology.
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
February 3rd 2025Naga Vara Kishore Pillarsetty, PhD, discusses advancements in radiopharmaceuticals for cancer therapy, noting common supply chain challenges, radiation safety measures, and patient misconceptions with the use of these drugs.
